blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3402521

EP3402521 - INHIBITION OF ALLERGIC REACTION USING AN IL-33 INHIBITOR [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.11.2021
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  19.10.2018
FormerThe international publication has been made
Status updated on  21.07.2017
Most recent event   Tooltip26.11.2021Application deemed to be withdrawnpublished on 29.12.2021  [2021/52]
Applicant(s)For all designated states
AnaptysBio, Inc.
10421 Pacific Center Court
San Diego, CA 92121 / US
[2018/47]
Inventor(s)01 / LONDEI, Marco
6417 La Jolla Scenic Drive
La Jolla California 92037 / US
 [2018/50]
Former [2018/47]01 / LONDEI, Marco
8875 Costa Verde Boulevard 702
San Diego California 92122 / US
Representative(s)Hoeger, Stellrecht & Partner Patentanwälte mbB
Uhlandstrasse 14c
70182 Stuttgart / DE
[2018/47]
Application number, filing date17739165.317.01.2017
[2018/47]
WO2017US13818
Priority number, dateUS201662278671P14.01.2016         Original published format: US 201662278671 P
[2018/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017124110
Date:20.07.2017
Language:EN
[2017/29]
Type: A1 Application with search report 
No.:EP3402521
Date:21.11.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 20.07.2017 takes the place of the publication of the European patent application.
[2018/47]
Search report(s)International search report - published on:US20.07.2017
(Supplementary) European search report - dispatched on:EP17.10.2019
ClassificationIPC:A61K39/395, A61P37/08, C07K16/24, C12N15/13
[2018/47]
CPC:
C07K16/244 (EP,KR,US); A61K39/3955 (KR); A61K39/395 (EP,US);
A61P11/06 (EP); A61P17/00 (EP); A61P37/08 (EP,KR,US);
A61K2039/505 (KR,US); A61P37/00 (EP,US); C07K2317/56 (US);
C07K2317/565 (US); C07K2317/76 (EP,KR,US); C07K2317/92 (US);
C07K2317/94 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/47]
TitleGerman:HEMMUNG VON ALLERGISCHER REAKTION UNTER VERWENDUNG EINES IL-33-INHIBITORS[2018/47]
English:INHIBITION OF ALLERGIC REACTION USING AN IL-33 INHIBITOR[2018/47]
French:INHIBITION DE RÉACTION ALLERGIQUE À L'AIDE D'UN INHIBITEUR D'IL-33[2018/47]
Entry into regional phase20.07.2018National basic fee paid 
20.07.2018Search fee paid 
20.07.2018Designation fee(s) paid 
20.07.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
20.07.2018Examination requested  [2018/47]
18.05.2020Amendment by applicant (claims and/or description)
03.08.2021Application deemed to be withdrawn, date of legal effect  [2021/52]
20.08.2021Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2021/52]
Fees paidRenewal fee
15.01.2019Renewal fee patent year 03
14.01.2020Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.01.202105   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2015106080  (ANAPTYSBIO INC [US], et al) [X] 1-15 * paragraphs [0067] , [0073]; examples 1-5; claims 1,26,27,33; sequences 1-231 *;
 [X]KR101567758B  (INHA IND PARTNERSHIP INST) [X] 1-4,11,15 * abstract *;
 [X]  - LIU X ET AL, "Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ELSEVIER, AMSTERDAM, NL, vol. 386, no. 1, doi:10.1016/J.BBRC.2009.06.008, ISSN 0006-291X, (20090814), pages 181 - 185, (20090607), XP026467441 [X] 1,3,11,15 * abstract *

DOI:   http://dx.doi.org/10.1016/j.bbrc.2009.06.008
 [A]  - Chu Et Al, "IL -33, but not thymic stromal lymphopoietin or IL -25, is central to mite and peanut allergic sensitization", J Allergy Clin Immunol, (20130101), pages 187 - 200, URL: https://www.sciencedirect.com/science/article/pii/S0091674912012833?via%3Dihub, (20160511), XP055271778 [A] 1-15 * abstract *
International search[X]WO2015106080  (ANAPTYSBIO INC [US], et al) [X] 1-6, 23 * entire document *;
 [A]US2014004107  (SMITH DIRK E [US], et al) [A] 1-6, 23 * entire document *;
 [A]US2012207752  (CHACKERIAN ALISSA A [US], et al) [A] 1-6, 23 * entire document *;
 [A]US2010260705  (MARTIN SEAMUS J [IE]) [A] 1-6, 23 * entire document *;
 [A]US2014271658  (MURPHY ANDREW J [US], et al) [A] 1-6, 23 * entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.